Balance Sheet
Liabilities and Shareholders Equity
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Short term Debt (2016 - 2023)

Aethlon Medical (AEMD) has disclosed Short term Debt for 13 consecutive years, with $214221.0 as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Short term Debt rose 37.55% year-over-year to $214221.0, compared with a TTM value of $214221.0 through Mar 2023, up 37.55%, and an annual FY2023 reading of $214221.0, up 37.55% over the prior year.
  • Short term Debt was $214221.0 for Q1 2023 at Aethlon Medical, up from $190397.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $214221.0 in Q1 2023 and bottomed at $83654.0 in Q1 2019.
  • Average Short term Debt over 5 years is $138988.8, with a median of $131844.0 recorded in 2020.
  • The sharpest move saw Short term Debt skyrocketed 59.44% in 2019, then dropped 14.47% in 2021.
  • Year by year, Short term Debt stood at $111212.0 in 2019, then grew by 18.46% to $131746.0 in 2020, then dropped by 1.04% to $130375.0 in 2021, then soared by 46.04% to $190397.0 in 2022, then increased by 12.51% to $214221.0 in 2023.
  • Business Quant data shows Short term Debt for AEMD at $214221.0 in Q1 2023, $190397.0 in Q4 2022, and $177527.0 in Q3 2022.